Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-11-16 LO FRANCIS Chief People Officer Sale −1,696 $47.56 $81K 304
2020-11-16 LO FRANCIS Chief People Officer Sale −304 $48.32 $15K 0
2020-11-16 LO FRANCIS Chief People Officer Option exercise · Stock Option (Right To Buy) −2,000 163,000
2020-11-16 GRIFFIN MICHELLE RENEE Director Option exercise +6,000 $7.80 $47K 6,000
2020-11-16 GRIFFIN MICHELLE RENEE Director Sale −5,021 $47.57 $239K 979
2020-11-16 GRIFFIN MICHELLE RENEE Director Sale −979 $48.30 $47K 0
2020-11-16 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −6,000 107,000
2020-11-16 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2020-11-16 HERSHBERG ROBERT Director Sale −1,777 $47.60 $85K 223
2020-11-16 HERSHBERG ROBERT Director Sale −223 $48.41 $11K 0
2020-11-16 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 61,000
2020-11-11 VIKING GLOBAL INVESTORS LP 10% owner Sale −2,500,000 $49.52 $123.8M 30,993,708
2020-11-11 VIKING GLOBAL PERFORMANCE LLC 10% owner Sale −2,500,000 $49.52 $123.8M 30,993,708
2020-11-09 Cohen Chad M Chief Financial Officer Option exercise +30,000 $6.32 $190K 31,000
2020-11-09 Cohen Chad M Chief Financial Officer Sale −17,151 $48.67 $835K 13,849
2020-11-09 Cohen Chad M Chief Financial Officer Sale −11,089 $49.63 $550K 2,760
2020-11-09 Cohen Chad M Chief Financial Officer Sale −1,760 $50.92 $90K 1,000
2020-11-09 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −30,000 520,000
2020-11-06 BALDO LANCE Chief Medical Officer Option exercise +6,250 $7.80 $49K 6,250
2020-11-06 BALDO LANCE Chief Medical Officer Sale −5,453 $50.54 $276K 797

Page 83 of 120 · 2,386 trades